

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 8.01311785 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 8.01311785 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 8.01311785 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 8.01311785 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 8.01311785 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 8.01311785 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.59949743 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.10931869 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.90631693 |
| 10 | microglial cell activation (GO:0001774) | 5.50086435 |
| 11 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.43746793 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 5.43300154 |
| 13 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.20290753 |
| 14 | response to host immune response (GO:0052572) | 5.20290753 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 5.19172921 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 5.15355312 |
| 17 | response to peptidoglycan (GO:0032494) | 5.07647872 |
| 18 | response to host (GO:0075136) | 4.72961017 |
| 19 | response to host defenses (GO:0052200) | 4.72961017 |
| 20 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.72961017 |
| 21 | macrophage activation (GO:0042116) | 4.49390895 |
| 22 | detection of other organism (GO:0098543) | 4.46807293 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.41006533 |
| 24 | positive regulation of antigen processing and presentation (GO:0002579) | 4.40871228 |
| 25 | respiratory burst (GO:0045730) | 4.34874190 |
| 26 | leukocyte aggregation (GO:0070486) | 4.28533515 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 4.24483986 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17168230 |
| 29 | detection of bacterium (GO:0016045) | 4.14438220 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.03275909 |
| 31 | myeloid cell activation involved in immune response (GO:0002275) | 3.94819899 |
| 32 | detection of external biotic stimulus (GO:0098581) | 3.93989787 |
| 33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.91021225 |
| 34 | detection of molecule of bacterial origin (GO:0032490) | 3.82383557 |
| 35 | I-kappaB phosphorylation (GO:0007252) | 3.80543345 |
| 36 | regulation of antigen processing and presentation (GO:0002577) | 3.71878789 |
| 37 | positive regulation of interferon-beta production (GO:0032728) | 3.70393168 |
| 38 | cellular extravasation (GO:0045123) | 3.66314244 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.66072464 |
| 40 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.65992893 |
| 41 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.64878453 |
| 42 | regulation of mononuclear cell migration (GO:0071675) | 3.63567855 |
| 43 | pinocytosis (GO:0006907) | 3.63436758 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.61100066 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.59958269 |
| 46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.58205621 |
| 47 | regulation of cholesterol storage (GO:0010885) | 3.56700424 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.54159978 |
| 49 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.49103159 |
| 50 | granulocyte activation (GO:0036230) | 3.48458948 |
| 51 | response to muramyl dipeptide (GO:0032495) | 3.45290357 |
| 52 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.42561027 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42143627 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.40717016 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.40438970 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 3.40296453 |
| 57 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.39035967 |
| 58 | apoptotic cell clearance (GO:0043277) | 3.36399158 |
| 59 | neutrophil activation (GO:0042119) | 3.35817270 |
| 60 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.33090888 |
| 61 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.31833532 |
| 62 | regulation of tolerance induction (GO:0002643) | 3.30665639 |
| 63 | negative regulation of cell killing (GO:0031342) | 3.30280647 |
| 64 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30280647 |
| 65 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29886016 |
| 66 | negative regulation of interleukin-17 production (GO:0032700) | 3.29839670 |
| 67 | defense response to protozoan (GO:0042832) | 3.28718258 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.26952848 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.25587390 |
| 70 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24791851 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23059697 |
| 72 | leukocyte degranulation (GO:0043299) | 3.19466515 |
| 73 | regulation of mast cell activation (GO:0033003) | 3.18265172 |
| 74 | lymphocyte chemotaxis (GO:0048247) | 3.18133281 |
| 75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.15798783 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.12739461 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 3.11915569 |
| 78 | B cell mediated immunity (GO:0019724) | 3.10689526 |
| 79 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.09347035 |
| 80 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.08923633 |
| 81 | neutrophil mediated immunity (GO:0002446) | 3.08649742 |
| 82 | T cell migration (GO:0072678) | 3.05105700 |
| 83 | negative regulation of mast cell activation (GO:0033004) | 3.04676226 |
| 84 | response to protozoan (GO:0001562) | 3.03712468 |
| 85 | B cell receptor signaling pathway (GO:0050853) | 3.02693254 |
| 86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.02507776 |
| 87 | positive regulation of type 2 immune response (GO:0002830) | 3.01885499 |
| 88 | mannose metabolic process (GO:0006013) | 3.01606720 |
| 89 | germinal center formation (GO:0002467) | 2.99810542 |
| 90 | response to interleukin-15 (GO:0070672) | 2.99353632 |
| 91 | positive regulation of mast cell degranulation (GO:0043306) | 2.99149801 |
| 92 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.99149801 |
| 93 | regulation of integrin activation (GO:0033623) | 2.98909099 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 2.98091042 |
| 95 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.97525655 |
| 96 | positive regulation of tolerance induction (GO:0002645) | 2.96965238 |
| 97 | myeloid leukocyte mediated immunity (GO:0002444) | 2.94888505 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 2.94454166 |
| 99 | regulation of macrophage chemotaxis (GO:0010758) | 2.94080390 |
| 100 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.94016597 |
| 101 | negative regulation of granulocyte differentiation (GO:0030853) | 2.93250974 |
| 102 | tolerance induction (GO:0002507) | 2.92440544 |
| 103 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.90979418 |
| 104 | reactive oxygen species biosynthetic process (GO:1903409) | 2.90962214 |
| 105 | regulation of regulatory T cell differentiation (GO:0045589) | 2.89759373 |
| 106 | positive regulation of leukocyte degranulation (GO:0043302) | 2.89631382 |
| 107 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89575938 |
| 108 | negative regulation of interleukin-6 production (GO:0032715) | 2.88994565 |
| 109 | superoxide anion generation (GO:0042554) | 2.88470953 |
| 110 | regulation of B cell differentiation (GO:0045577) | 2.88325317 |
| 111 | myeloid leukocyte activation (GO:0002274) | 2.87835832 |
| 112 | type I interferon signaling pathway (GO:0060337) | 2.87718227 |
| 113 | cellular response to type I interferon (GO:0071357) | 2.87718227 |
| 114 | regulation of regulated secretory pathway (GO:1903305) | 2.87621066 |
| 115 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.87013562 |
| 116 | natural killer cell mediated immunity (GO:0002228) | 2.87013562 |
| 117 | neutrophil chemotaxis (GO:0030593) | 2.86800577 |
| 118 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85336632 |
| 119 | response to type I interferon (GO:0034340) | 2.85140142 |
| 120 | positive regulation of macrophage cytokine production (GO:0060907) | 2.85123307 |
| 121 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.85089076 |
| 122 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.85089076 |
| 123 | positive regulation of B cell differentiation (GO:0045579) | 2.84399866 |
| 124 | T-helper 1 type immune response (GO:0042088) | 2.84185379 |
| 125 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.84147943 |
| 126 | positive regulation of lymphocyte migration (GO:2000403) | 2.84042088 |
| 127 | leukotriene metabolic process (GO:0006691) | 2.83806021 |
| 128 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.82815241 |
| 129 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.81991706 |
| 130 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.81991706 |
| 131 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81281701 |
| 132 | positive regulation of chemokine production (GO:0032722) | 2.81189393 |
| 133 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.80907206 |
| 134 | neutrophil migration (GO:1990266) | 2.78455430 |
| 135 | regulation of interferon-beta production (GO:0032648) | 2.77699459 |
| 136 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.77390917 |
| 137 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76802461 |
| 138 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.72146351 |
| 139 | positive regulation of T cell migration (GO:2000406) | 2.69633123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.39632211 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.34499030 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.95382026 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 5.11377868 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.76168642 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.10381202 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.08310978 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.35442850 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28073332 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.17982642 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.03112876 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.93158369 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.75932505 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46584814 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.46199881 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.42345157 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42114386 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40901524 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34355934 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34207728 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.32914569 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20584903 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.16613324 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07125198 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95466732 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.92083229 |
| 27 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.90152869 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.88557668 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84415208 |
| 30 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.82764837 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81075688 |
| 32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79340591 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75892073 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70056074 |
| 35 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69325764 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68752028 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.63036678 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62492926 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59773817 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55399278 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.52866564 |
| 42 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46111962 |
| 43 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45878242 |
| 44 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45307694 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44648744 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.39567979 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39539093 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38960438 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.38365080 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33305021 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32037041 |
| 52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24701976 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22303928 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20911291 |
| 55 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20236062 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19351450 |
| 57 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17345317 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16156725 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15819023 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12287900 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.11133724 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11059946 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10112184 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06121618 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05792400 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04884729 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03607694 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02753017 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02357779 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01587720 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01560785 |
| 72 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99823935 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97781649 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97375057 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97228289 |
| 76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96406973 |
| 77 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.96032097 |
| 78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95936389 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95756041 |
| 80 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94633092 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93441207 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92152046 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90707892 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88419029 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87203760 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87114622 |
| 87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86940731 |
| 88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86070544 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85347302 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84946056 |
| 91 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.82630746 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81990622 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81913625 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81600361 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81084824 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78943960 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78800841 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.78797507 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78667547 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78156070 |
| 101 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78031535 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77959738 |
| 103 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76844043 |
| 104 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75806992 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74948055 |
| 106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74420015 |
| 107 | MAF_26560356_Chip-Seq_TH2_Human | 0.73631948 |
| 108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73185147 |
| 109 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.71230630 |
| 110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.70426662 |
| 111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69921555 |
| 112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69921555 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68937323 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67899664 |
| 115 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.66228350 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65956877 |
| 117 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.63862667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.07441131 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.86737780 |
| 3 | MP0003303_peritoneal_inflammation | 3.73332162 |
| 4 | MP0003436_decreased_susceptibility_to | 3.71326049 |
| 5 | MP0006082_CNS_inflammation | 3.38233164 |
| 6 | MP0002419_abnormal_innate_immunity | 3.26988735 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.21063251 |
| 8 | MP0009785_altered_susceptibility_to | 2.86595105 |
| 9 | MP0009840_abnormal_foam_cell | 2.85966285 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.85406535 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.83884300 |
| 12 | MP0005025_abnormal_response_to | 2.64032610 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.60058791 |
| 14 | MP0001790_abnormal_immune_system | 2.57626755 |
| 15 | MP0005387_immune_system_phenotype | 2.57626755 |
| 16 | MP0003724_increased_susceptibility_to | 2.53396555 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.43829289 |
| 18 | MP0000604_amyloidosis | 2.32078086 |
| 19 | MP0004510_myositis | 2.31645053 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.28396021 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.27991100 |
| 22 | MP0001800_abnormal_humoral_immune | 2.25641103 |
| 23 | MP0003690_abnormal_glial_cell | 2.19085464 |
| 24 | MP0002723_abnormal_immune_serum | 2.18499540 |
| 25 | MP0000685_abnormal_immune_system | 2.08532519 |
| 26 | MP0000569_abnormal_digit_pigmentation | 2.06217935 |
| 27 | MP0003075_altered_response_to | 2.02023962 |
| 28 | MP0001819_abnormal_immune_cell | 1.95031938 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.93426968 |
| 30 | MP0005671_abnormal_response_to | 1.88124325 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.82639981 |
| 32 | MP0004947_skin_inflammation | 1.81454843 |
| 33 | MP0000343_altered_response_to | 1.76824691 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.76675958 |
| 35 | MP0002405_respiratory_system_inflammati | 1.72965708 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.71687352 |
| 37 | MP0003448_altered_tumor_morphology | 1.70135449 |
| 38 | MP0008469_abnormal_protein_level | 1.69794149 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.63009031 |
| 40 | MP0005451_abnormal_body_composition | 1.58675321 |
| 41 | MP0009278_abnormal_bone_marrow | 1.57268271 |
| 42 | MP0005310_abnormal_salivary_gland | 1.56473966 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.44759942 |
| 44 | MP0009764_decreased_sensitivity_to | 1.44024253 |
| 45 | MP0005166_decreased_susceptibility_to | 1.41260694 |
| 46 | MP0008438_abnormal_cutaneous_collagen | 1.39316654 |
| 47 | MP0002132_abnormal_respiratory_system | 1.38301771 |
| 48 | MP0005083_abnormal_biliary_tract | 1.36115867 |
| 49 | MP0000716_abnormal_immune_system | 1.35321312 |
| 50 | MP0003866_abnormal_defecation | 1.33630300 |
| 51 | MP0001853_heart_inflammation | 1.29580651 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.29384124 |
| 53 | MP0010307_abnormal_tumor_latency | 1.28003766 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.26565260 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.24071499 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.24065852 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.20511407 |
| 58 | MP0002398_abnormal_bone_marrow | 1.17193779 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.16228963 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.15704711 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.12019788 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.11643098 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.11349554 |
| 64 | MP0000858_altered_metastatic_potential | 1.09035923 |
| 65 | MP0002429_abnormal_blood_cell | 1.08785010 |
| 66 | MP0001851_eye_inflammation | 1.08750160 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.05973705 |
| 68 | MP0002006_tumorigenesis | 1.05139596 |
| 69 | MP0005390_skeleton_phenotype | 1.04389856 |
| 70 | MP0003828_pulmonary_edema | 1.04336087 |
| 71 | MP0004381_abnormal_hair_follicle | 1.04264099 |
| 72 | MP0002254_reproductive_system_inflammat | 1.04175478 |
| 73 | MP0005174_abnormal_tail_pigmentation | 1.03876691 |
| 74 | MP0002722_abnormal_immune_system | 1.02770441 |
| 75 | MP0002933_joint_inflammation | 1.01824221 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 1.00147726 |
| 77 | MP0009763_increased_sensitivity_to | 0.99123909 |
| 78 | MP0002332_abnormal_exercise_endurance | 0.97934860 |
| 79 | MP0002396_abnormal_hematopoietic_system | 0.96181851 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 0.93950638 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.93950638 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 0.92346572 |
| 83 | MP0005164_abnormal_response_to | 0.91531873 |
| 84 | MP0000249_abnormal_blood_vessel | 0.91394314 |
| 85 | MP0001663_abnormal_digestive_system | 0.90661858 |
| 86 | MP0002138_abnormal_hepatobiliary_system | 0.88463023 |
| 87 | MP0005076_abnormal_cell_differentiation | 0.87640183 |
| 88 | MP0003195_calcinosis | 0.85957739 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.85151567 |
| 90 | MP0003806_abnormal_nucleotide_metabolis | 0.84994606 |
| 91 | MP0002090_abnormal_vision | 0.80264071 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.79838313 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.79663497 |
| 94 | MP0006054_spinal_hemorrhage | 0.75800739 |
| 95 | MP0003795_abnormal_bone_structure | 0.74978744 |
| 96 | MP0004858_abnormal_nervous_system | 0.73700130 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.72219512 |
| 98 | MP0000609_abnormal_liver_physiology | 0.71635269 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.71176218 |
| 100 | MP0000920_abnormal_myelination | 0.71058671 |
| 101 | MP0003045_fibrosis | 0.70954493 |
| 102 | MP0001958_emphysema | 0.70723141 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.68928690 |
| 104 | MP0008874_decreased_physiological_sensi | 0.68839647 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.67984247 |
| 106 | MP0008004_abnormal_stomach_pH | 0.67858177 |
| 107 | MP0004883_abnormal_blood_vessel | 0.67763766 |
| 108 | MP0008260_abnormal_autophagy | 0.67399172 |
| 109 | MP0000371_diluted_coat_color | 0.66574180 |
| 110 | MP0004130_abnormal_muscle_cell | 0.66531562 |
| 111 | MP0005023_abnormal_wound_healing | 0.65748911 |
| 112 | MP0003091_abnormal_cell_migration | 0.65304864 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63300062 |
| 114 | MP0005197_abnormal_uvea_morphology | 0.61773798 |
| 115 | MP0001915_intracranial_hemorrhage | 0.61188716 |
| 116 | MP0003634_abnormal_glial_cell | 0.60518382 |
| 117 | MP0001873_stomach_inflammation | 0.58695999 |
| 118 | MP0000490_abnormal_crypts_of | 0.57554613 |
| 119 | MP0002877_abnormal_melanocyte_morpholog | 0.57525606 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 0.57303011 |
| 121 | MP0003186_abnormal_redox_activity | 0.55132398 |
| 122 | MP0000598_abnormal_liver_morphology | 0.55054699 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.53409078 |
| 124 | MP0005535_abnormal_body_temperature | 0.52463919 |
| 125 | MP0003252_abnormal_bile_duct | 0.50904152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.76073353 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.84837544 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 6.19147082 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 6.04334641 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.84127921 |
| 6 | Eczematoid dermatitis (HP:0000976) | 5.66403631 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.56586982 |
| 8 | Glomerulonephritis (HP:0000099) | 5.45686176 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.36235414 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.94255508 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.88165218 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.57792696 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.57792696 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 4.57792696 |
| 15 | Disinhibition (HP:0000734) | 4.13746685 |
| 16 | Complement deficiency (HP:0004431) | 4.11838795 |
| 17 | Abnormality of complement system (HP:0005339) | 3.99607609 |
| 18 | Axonal loss (HP:0003447) | 3.97933079 |
| 19 | Prolonged bleeding time (HP:0003010) | 3.94058206 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.87624039 |
| 21 | Mucopolysacchariduria (HP:0008155) | 3.87624039 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.85351989 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.73216630 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.72293605 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.67083728 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.67083728 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.67083728 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.62911687 |
| 29 | Gingivitis (HP:0000230) | 3.58981054 |
| 30 | Encephalitis (HP:0002383) | 3.47804548 |
| 31 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.46213670 |
| 32 | Keratoconjunctivitis (HP:0001096) | 3.43796943 |
| 33 | Loss of speech (HP:0002371) | 3.36615136 |
| 34 | Recurrent skin infections (HP:0001581) | 3.35832225 |
| 35 | Epistaxis (HP:0000421) | 3.28361036 |
| 36 | Nephritis (HP:0000123) | 3.28272449 |
| 37 | Prostate neoplasm (HP:0100787) | 3.27809875 |
| 38 | Myositis (HP:0100614) | 3.27252258 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 3.24076948 |
| 40 | Obstructive lung disease (HP:0006536) | 3.24076948 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 3.22354855 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.22354855 |
| 43 | Orchitis (HP:0100796) | 3.19355717 |
| 44 | Pustule (HP:0200039) | 3.16912759 |
| 45 | T lymphocytopenia (HP:0005403) | 3.14180928 |
| 46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.09612701 |
| 47 | Chest pain (HP:0100749) | 3.09327538 |
| 48 | Agnosia (HP:0010524) | 3.05879178 |
| 49 | Hemoptysis (HP:0002105) | 3.05394726 |
| 50 | Myocardial infarction (HP:0001658) | 3.03436171 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 3.02304426 |
| 52 | Increased IgE level (HP:0003212) | 3.01455091 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.98520231 |
| 54 | Episodic fever (HP:0001954) | 2.97970267 |
| 55 | Purpura (HP:0000979) | 2.94505276 |
| 56 | Thick nail (HP:0001805) | 2.93135378 |
| 57 | Stomatitis (HP:0010280) | 2.91236949 |
| 58 | Optic neuritis (HP:0100653) | 2.83519663 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.83519663 |
| 60 | Upper motor neuron abnormality (HP:0002127) | 2.81438115 |
| 61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.75190069 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.75087085 |
| 63 | Periodontitis (HP:0000704) | 2.70733597 |
| 64 | Increased IgM level (HP:0003496) | 2.69323685 |
| 65 | Hematochezia (HP:0002573) | 2.68475863 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.66686777 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.65405610 |
| 68 | J-shaped sella turcica (HP:0002680) | 2.61954124 |
| 69 | Abnormality of T cells (HP:0002843) | 2.59180579 |
| 70 | Pathologic fracture (HP:0002756) | 2.55861155 |
| 71 | Pulmonary embolism (HP:0002204) | 2.55813563 |
| 72 | Gangrene (HP:0100758) | 2.54969869 |
| 73 | Anorexia (HP:0002039) | 2.54538413 |
| 74 | Peritonitis (HP:0002586) | 2.50289575 |
| 75 | Recurrent viral infections (HP:0004429) | 2.47893414 |
| 76 | Abnormal platelet volume (HP:0011876) | 2.47605437 |
| 77 | Increased serum ferritin (HP:0003281) | 2.45278137 |
| 78 | Gastrointestinal inflammation (HP:0004386) | 2.44989829 |
| 79 | Mutism (HP:0002300) | 2.42312228 |
| 80 | Granulocytopenia (HP:0001913) | 2.42184977 |
| 81 | Basal ganglia calcification (HP:0002135) | 2.41866043 |
| 82 | Abnormality of the lumbar spine (HP:0100712) | 2.41313280 |
| 83 | Asymmetric septal hypertrophy (HP:0001670) | 2.40850576 |
| 84 | Cellulitis (HP:0100658) | 2.39031870 |
| 85 | Thoracic kyphosis (HP:0002942) | 2.36890229 |
| 86 | Urticaria (HP:0001025) | 2.36512662 |
| 87 | Panhypogammaglobulinemia (HP:0003139) | 2.34070021 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.34014734 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.31927244 |
| 90 | Autoimmune hemolytic anemia (HP:0001890) | 2.29335042 |
| 91 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.25887005 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 2.25887005 |
| 93 | Vertigo (HP:0002321) | 2.25402346 |
| 94 | Abnormality of the pleura (HP:0002103) | 2.25370445 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 2.25223990 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 2.22751740 |
| 97 | Apathy (HP:0000741) | 2.22390470 |
| 98 | Diminished motivation (HP:0000745) | 2.22158690 |
| 99 | Peripheral demyelination (HP:0011096) | 2.22056589 |
| 100 | Spontaneous hematomas (HP:0007420) | 2.20152418 |
| 101 | Hypergammaglobulinemia (HP:0010702) | 2.20072386 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 2.19552257 |
| 103 | Eosinophilia (HP:0001880) | 2.19311507 |
| 104 | Hypochromic microcytic anemia (HP:0004840) | 2.19305169 |
| 105 | Osteomyelitis (HP:0002754) | 2.18187794 |
| 106 | Vasculitis (HP:0002633) | 2.15690205 |
| 107 | Colitis (HP:0002583) | 2.14664452 |
| 108 | Inappropriate behavior (HP:0000719) | 2.12694537 |
| 109 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.12588177 |
| 110 | Conjunctival telangiectasia (HP:0000524) | 2.12578548 |
| 111 | Hypochromic anemia (HP:0001931) | 2.12421688 |
| 112 | Bone pain (HP:0002653) | 2.12394227 |
| 113 | Pulmonary infiltrates (HP:0002113) | 2.11818378 |
| 114 | Slow saccadic eye movements (HP:0000514) | 2.11709445 |
| 115 | Alveolar cell carcinoma (HP:0006519) | 2.11237951 |
| 116 | Arterial thrombosis (HP:0004420) | 2.11076569 |
| 117 | Polyneuropathy (HP:0001271) | 2.10534625 |
| 118 | Joint hemorrhage (HP:0005261) | 2.10253741 |
| 119 | Tetraparesis (HP:0002273) | 2.10178330 |
| 120 | Progressive visual loss (HP:0000529) | 2.09583189 |
| 121 | Sepsis (HP:0100806) | 2.06650702 |
| 122 | Lymphopenia (HP:0001888) | 2.03063100 |
| 123 | Glomerulopathy (HP:0100820) | 2.02775122 |
| 124 | Retinal atrophy (HP:0001105) | 2.02698673 |
| 125 | Leukocytosis (HP:0001974) | 2.02662586 |
| 126 | Abnormality of the endocardium (HP:0004306) | 1.98797850 |
| 127 | Joint swelling (HP:0001386) | 1.96794611 |
| 128 | Spondylolisthesis (HP:0003302) | 1.96661881 |
| 129 | Recurrent pneumonia (HP:0006532) | 1.96507784 |
| 130 | Global brain atrophy (HP:0002283) | 1.96147162 |
| 131 | Menorrhagia (HP:0000132) | 1.95199165 |
| 132 | Petechiae (HP:0000967) | 1.94905376 |
| 133 | Vertebral compression fractures (HP:0002953) | 1.94614398 |
| 134 | Amaurosis fugax (HP:0100576) | 1.93885903 |
| 135 | Neurofibrillary tangles (HP:0002185) | 1.93677590 |
| 136 | Personality changes (HP:0000751) | 1.93546113 |
| 137 | Acne (HP:0001061) | 1.92860571 |
| 138 | Progressive neurologic deterioration (HP:0002344) | 1.92191828 |
| 139 | Deformed sella turcica (HP:0002681) | 1.90883425 |
| 140 | Chronic otitis media (HP:0000389) | 1.90522415 |
| 141 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90288136 |
| 142 | Meningitis (HP:0001287) | 1.89804273 |
| 143 | Inflammation of the large intestine (HP:0002037) | 1.89450782 |
| 144 | Amyloidosis (HP:0011034) | 1.88967826 |
| 145 | Microcytic anemia (HP:0001935) | 1.88206492 |
| 146 | Keratitis (HP:0000491) | 1.87949422 |
| 147 | Increased mean platelet volume (HP:0011877) | 1.86674224 |
| 148 | Arthralgia (HP:0002829) | 1.85989735 |
| 149 | Gingival bleeding (HP:0000225) | 1.83100760 |
| 150 | Abnormality of the prostate (HP:0008775) | 1.76596591 |
| 151 | Supranuclear gaze palsy (HP:0000605) | 1.76025190 |
| 152 | Frequent falls (HP:0002359) | 1.75949355 |
| 153 | Increased CSF protein (HP:0002922) | 1.74394743 |
| 154 | Abnormality of the thoracic spine (HP:0100711) | 1.74333437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.94349671 |
| 2 | RIPK4 | 3.55818576 |
| 3 | TYK2 | 3.42240249 |
| 4 | TBK1 | 3.32263545 |
| 5 | IRAK4 | 2.87980634 |
| 6 | KIT | 2.87761037 |
| 7 | MAP3K14 | 2.82520329 |
| 8 | TGFBR2 | 2.74736464 |
| 9 | IRAK3 | 2.70417686 |
| 10 | ERN1 | 2.51760056 |
| 11 | MAP4K1 | 2.44789444 |
| 12 | PRPF4B | 2.29600058 |
| 13 | CSF1R | 2.27822125 |
| 14 | IKBKE | 2.15918890 |
| 15 | FGR | 2.14177103 |
| 16 | FES | 2.06103452 |
| 17 | JAK1 | 1.94783186 |
| 18 | TNK2 | 1.79975696 |
| 19 | CAMK1D | 1.78935593 |
| 20 | MAP3K13 | 1.75556154 |
| 21 | CSK | 1.74231367 |
| 22 | TAOK1 | 1.74143017 |
| 23 | IKBKB | 1.70071208 |
| 24 | PBK | 1.67262427 |
| 25 | TAOK3 | 1.66415918 |
| 26 | NEK9 | 1.55166343 |
| 27 | HCK | 1.52328545 |
| 28 | ZAP70 | 1.51886610 |
| 29 | GRK7 | 1.50625526 |
| 30 | TRIB3 | 1.50195137 |
| 31 | JAK3 | 1.48086413 |
| 32 | PKN2 | 1.47865606 |
| 33 | EPHB1 | 1.46352140 |
| 34 | TXK | 1.45277491 |
| 35 | SYK | 1.39170964 |
| 36 | STK10 | 1.35314498 |
| 37 | TAOK2 | 1.30828167 |
| 38 | MAP2K3 | 1.30239253 |
| 39 | LYN | 1.28910225 |
| 40 | IRAK1 | 1.28226868 |
| 41 | RIPK1 | 1.27381267 |
| 42 | JAK2 | 1.23257754 |
| 43 | CAMK1G | 1.21776710 |
| 44 | MATK | 1.20294092 |
| 45 | LCK | 1.19402237 |
| 46 | IRAK2 | 1.14111581 |
| 47 | TTN | 1.13656713 |
| 48 | SCYL2 | 1.13264929 |
| 49 | SIK3 | 1.12065884 |
| 50 | CAMKK2 | 1.07371757 |
| 51 | PTK6 | 1.05309446 |
| 52 | BTK | 1.04764137 |
| 53 | MST1R | 1.02593688 |
| 54 | MAP3K5 | 0.99621558 |
| 55 | EGFR | 0.89891127 |
| 56 | NME2 | 0.89548067 |
| 57 | MAP3K3 | 0.84977561 |
| 58 | CAMKK1 | 0.81358750 |
| 59 | DAPK2 | 0.81246754 |
| 60 | MOS | 0.81152330 |
| 61 | RPS6KA4 | 0.80386801 |
| 62 | CHUK | 0.79450556 |
| 63 | MARK2 | 0.79346250 |
| 64 | BMX | 0.78029140 |
| 65 | PRKCD | 0.72104453 |
| 66 | CLK1 | 0.71418222 |
| 67 | CDC42BPA | 0.71239567 |
| 68 | PAK4 | 0.71085859 |
| 69 | LRRK2 | 0.68641496 |
| 70 | PIM2 | 0.68178606 |
| 71 | ITK | 0.67870285 |
| 72 | GRK6 | 0.66716467 |
| 73 | MARK3 | 0.65853182 |
| 74 | SIK2 | 0.65120769 |
| 75 | TEC | 0.64091396 |
| 76 | FGFR4 | 0.62900586 |
| 77 | MAP3K2 | 0.62437346 |
| 78 | PTK2B | 0.62056759 |
| 79 | HIPK2 | 0.62005982 |
| 80 | FYN | 0.61018351 |
| 81 | ABL2 | 0.60404047 |
| 82 | MAP3K6 | 0.60255387 |
| 83 | ABL1 | 0.59566667 |
| 84 | EPHA3 | 0.57339544 |
| 85 | SGK3 | 0.53899748 |
| 86 | TESK2 | 0.52569702 |
| 87 | MAPK7 | 0.51152585 |
| 88 | MAPK12 | 0.49932912 |
| 89 | FGFR3 | 0.49838640 |
| 90 | PIM1 | 0.48201412 |
| 91 | TRPM7 | 0.47527351 |
| 92 | IGF1R | 0.46751708 |
| 93 | PRKD2 | 0.45264284 |
| 94 | KSR2 | 0.44729747 |
| 95 | PDPK1 | 0.42753887 |
| 96 | MAP3K11 | 0.42009191 |
| 97 | NLK | 0.41893419 |
| 98 | PIK3CG | 0.41557073 |
| 99 | PRKCQ | 0.41527281 |
| 100 | STK24 | 0.41463430 |
| 101 | CDK6 | 0.41268673 |
| 102 | BMPR2 | 0.40965806 |
| 103 | ARAF | 0.40828452 |
| 104 | STK4 | 0.40525926 |
| 105 | PDK1 | 0.40405806 |
| 106 | MAPKAPK2 | 0.39091322 |
| 107 | SGK2 | 0.38243096 |
| 108 | CDK19 | 0.37851838 |
| 109 | MAP2K4 | 0.37373512 |
| 110 | EIF2AK2 | 0.36162587 |
| 111 | PRKCH | 0.34598124 |
| 112 | RPS6KA6 | 0.34383288 |
| 113 | MAP3K7 | 0.34080730 |
| 114 | DYRK1B | 0.33957057 |
| 115 | STK11 | 0.32313429 |
| 116 | KSR1 | 0.31180586 |
| 117 | ADRBK2 | 0.30738263 |
| 118 | MAP2K6 | 0.30573281 |
| 119 | DAPK3 | 0.30331476 |
| 120 | RAF1 | 0.29250373 |
| 121 | ACVR1B | 0.28425942 |
| 122 | YES1 | 0.28227517 |
| 123 | RET | 0.27474830 |
| 124 | DYRK3 | 0.27360097 |
| 125 | RPS6KA2 | 0.27148632 |
| 126 | PKN1 | 0.26495634 |
| 127 | SRC | 0.26494582 |
| 128 | RPS6KC1 | 0.26161686 |
| 129 | RPS6KL1 | 0.26161686 |
| 130 | GSK3A | 0.24892941 |
| 131 | MAP3K1 | 0.24581204 |
| 132 | PLK2 | 0.24334355 |
| 133 | MAPK4 | 0.23708367 |
| 134 | MAP3K10 | 0.22659721 |
| 135 | INSR | 0.22313711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.27044505 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.52908938 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.36365671 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.19088812 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.18183556 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.70350301 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.60310016 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.55289595 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.33033045 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.21469054 |
| 11 | Phagosome_Homo sapiens_hsa04145 | 2.16302315 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.05525075 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.99870945 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.84590664 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.83456135 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79719575 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.63522883 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.62282387 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61133772 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.60249387 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57515011 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56853894 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.56186392 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45017863 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44771707 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.43719823 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.42871109 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39443016 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37819324 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34879231 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33793859 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31515503 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30522570 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.30114693 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25139564 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22964434 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19503108 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.14887640 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.14741780 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14475589 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.10113381 |
| 42 | Allograft rejection_Homo sapiens_hsa05330 | 1.07962543 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04847438 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 1.04114858 |
| 45 | Asthma_Homo sapiens_hsa05310 | 0.99973485 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98423633 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96108401 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93880308 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89417242 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.89213537 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.88066126 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87695095 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86854705 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80090374 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80046507 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74926765 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73769335 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73252766 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72581393 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71522687 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67028655 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66179447 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.65981891 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62431115 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.61712531 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61689581 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59458569 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59298434 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59287601 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.57616486 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53295617 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51907609 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51312205 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50526498 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50357724 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49625983 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48942012 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48701644 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48274072 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47118644 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46433577 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45988980 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45459854 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44136310 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43587888 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42025515 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40874838 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40749170 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.39702765 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39194270 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.37802499 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35496083 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34983342 |
| 94 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34912318 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31445501 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31342817 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30942088 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30678910 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29137159 |
| 100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28965190 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27559721 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27212074 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26678036 |
| 104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25162352 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23837567 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.23741206 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23629356 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23257164 |
| 109 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22378552 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.22130857 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20057766 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.19380755 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19330999 |
| 114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.18239361 |
| 115 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17982604 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.17100754 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16743307 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15846371 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.14281456 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.14220518 |

